Bingji Li

1.3k citations
14 papers · 1.1k · 1 hit paper · h-index 12

Impact in

  • Oncology top 5%
    • Peptidase Inhibition and Analysis
    • Cancer Immunotherapy and Biomarkers
    • Cancer Cells and Metastasis
    • Pancreatic and Hepatic Oncology Research
  • Immunology top 10%
    • Immune cells in cancer
    • Immune Cell Function and Interaction

Papers in

    • IL-33, ST2, and ILC Pathways 5
    • Immune Cell Function and Interaction 2
    • Inflammation biomarkers and pathways 1

Bingji Li

14 papers receiving 1.1k citations

Bingji Li's Hit Papers

FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3–CCL2 Signaling 2016 · 563 citations
5630+3+6Years since publication100200300400500

Peers

Bingji Li
Comparison fields: 5 of 82
  • Oncology 517
  • Immunology 385
  • Cancer Research 192
  • Immunology and Allergy 41
  • Aquatic Science 44
Replace Haifeng Zhao with:
Haifeng Zhao China
H. Herschel Conaway United States
Eli Reich Israel
E Abe Japan
Katharina Röck Germany
Chunchao Zhu China
Kai‐Kai Chang China
Chang-Goo Huh United States
Carina Scholtysek Germany
Chun Guo China
Bingji Li relative to Haifeng Zhao China Haifeng Zhao's profile →
Citations per field
00.5×3.0×
Haifeng Zhao · 1×
Citations per year

Countries citing papers authored by Bingji Li

Since Specialization
Citations

This map shows the geographic impact of Bingji Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingji Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingji Li more than expected).

Fields of papers citing papers by Bingji Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bingji Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingji Li. The network helps show where Bingji Li may publish in the future.

Co-authors

The 25 scholars most cited alongside Bingji Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bingji Li Line = papers co-authored together Bingji Li links everyone, so they are left out of the graph.

All Works

14 of 14 papers shown
#Work
1
FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3–CCL2 Signaling
Hit paper breakdown →
2016563
2 2014141
3 201970
4 201744
5 202141
6 201940
7 200834
8 202032
9 201629
10 201525
11 202218
12 201812
13
[The pharmacological effects of hippocampus capsule on enhancing sexual functions of rats].
200310
14 20191

About Bingji Li

Bingji Li is a scholar working on Immunology, Surgery, Molecular Biology, Oncology and Dermatology, having authored 14 papers that have together received 1.1k indexed citations. Recurring topics across this work include IL-33, ST2, and ILC Pathways (5 papers), Peptidase Inhibition and Analysis (2 papers), Protein Hydrolysis and Bioactive Peptides (2 papers), Immune Cell Function and Interaction (2 papers), Mycobacterium research and diagnosis (2 papers), Allergic Rhinitis and Sensitization (1 paper), Inflammation biomarkers and pathways (1 paper) and Dermatology and Skin Diseases (1 paper). The work is most often cited by research in Oncology (517 citations), Immunology (385 citations), Cancer Research (192 citations), Immunology and Allergy (41 citations) and Aquatic Science (44 citations). Bingji Li has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Rui He, Yuli Lin, Xuguang Yang, Wei Yin, Yongyong Shi, Weiren Liu, Yiwei Chu, Jia Fan, Yongjun Dang and Wenjie Yue. Their work appears in journals such as Cellular and Molecular Immunology, Neoplasia, Science Immunology, Immunology and Oncotarget.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact